Admission screening testing of patients and staff N95 respirators are cost-effective in reducing COVID-19 hospital-acquired infections.
McAndrew F, Abeysuriya RG, Sacks-Davis R, Sammann M, Lister DM, West D, Majumdar SS, Scott N
COVID-19
Living evidence syntheses: the emerging opportunity to increase evidence-informed health policy in Australia.
Chakraborty SP, Collie A, Hodder R, Majumdar SS, Sutherland K, Towler B, Vogel J, Wilson A, Wolfenden L, Green S, Turner T
COVID-19 outbreaks in residential aged care facilities: an agent-based modeling study.
McAndrew F, Sacks-Davis R, Abeysuriya RG, Delport D, West D, Parta I, Majumdar S, Hellard M, Scott N
COVID-19
The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study.
Canevari JT, Cheng AC, Wu L, Rowe SL, Wollersheim DE, West D, Majumdar SS, Sullivan SG
COVID-19
Effectiveness of community-based oral antiviral treatments against severe COVID-19 outcomes in people 70 years and over in Victoria, Australia, 2022: an observational study
Van Heer C, Majumdar SS, Parta I, Martinie M, Dawson R, West D, Hewett L, Lister D, Sutton B, O’Brien DP, Cowie BC
COVID-19
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K on behalf of the TB-PRACTECAL team
Global Infectious Disease Threats Tuberculosis (TB)